101 related articles for article (PubMed ID: 12637894)
21. Editorial comment: which is the preferred drug-eluting stent?
Brodie BR
J Interv Cardiol; 2006 Feb; 19(1):39-42. PubMed ID: 16483338
[No Abstract] [Full Text] [Related]
22. Sirolimus-eluting stent implantation in a heart transplant recipient.
Tomai F; Gagliardi G; Proietti I
Ital Heart J; 2004 May; 5(5):408-9. PubMed ID: 15185909
[No Abstract] [Full Text] [Related]
23. Drug-coated stents: preventing restenosis in coronary artery disease.
Stanik-Hutt JA
J Cardiovasc Nurs; 2004; 19(6):404-8. PubMed ID: 15529062
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
[TBL] [Abstract][Full Text] [Related]
25. The rush is on to acquire drug-eluting stents.
Hosp Mater Manage; 2003 Jun; 28(6):2, 11. PubMed ID: 12825380
[No Abstract] [Full Text] [Related]
26. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future.
Leon MB; Bakhai A;
Am Heart J; 2003 Oct; 146(4 Suppl):S13-7. PubMed ID: 14564301
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stents: preventing restenosis.
Slavin L; Chhabra A; Tobis JM
Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
[TBL] [Abstract][Full Text] [Related]
29. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
[TBL] [Abstract][Full Text] [Related]
30. Restenosis treatment in the drug-eluting stent era.
Presbitero P; Boccuzzi G
Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
[TBL] [Abstract][Full Text] [Related]
31. [Drug-eluting stents in coronary arteries. The risk of restenosis is drastically reduced].
Tornvall P
Lakartidningen; 2004 Dec; 101(51-52):4175. PubMed ID: 15658586
[No Abstract] [Full Text] [Related]
32. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
33. Newer stents: looking at the horizon.
Ramcharitar S; Serruys PW
Indian Heart J; 2007; 59(2 Suppl B):B59-71. PubMed ID: 19153438
[TBL] [Abstract][Full Text] [Related]
34. [Progress on reasech of drug-coated stent].
Zhang L; Liu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):235-9. PubMed ID: 17333930
[TBL] [Abstract][Full Text] [Related]
35. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
Liuzzo JP; Ambrose JA; Coppola JT
J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
[TBL] [Abstract][Full Text] [Related]
36. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
J Am Coll Cardiol; 2009 Mar; 53(9):812-3. PubMed ID: 19245976
[No Abstract] [Full Text] [Related]
37. Safety and efficacy of drug-eluting stents.
Williams DO; Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794
[TBL] [Abstract][Full Text] [Related]
38. Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.
Schofer J; Bode C; Silber S
Herz; 2004 Mar; 29(2):195-200. PubMed ID: 15057441
[TBL] [Abstract][Full Text] [Related]
39. [Development of drug coating on drug eluting stents].
Luo LL; Wang GX; Yin TY
Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of lesions with a high risk of stenosis. Comparative study in 300 patients of rapamycin- and Paclitaxel-eluting polymer-based stents, and bare metal stents].
de la Torre Hernández JM; Sainz Laso F; Ruisánchez C; Zueco J; Figueroa A; Colman T
Rev Esp Cardiol; 2005 Mar; 58(3):262-9. PubMed ID: 15766448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
